Raymond James & Associates’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.29M | Sell |
|
|||||
|
2024
Q2 | $3.11M | Sell |
|
|||||
|
2024
Q1 | $1.88M | Buy |
|
|||||
|
2023
Q4 | $1.13M | Buy |
|
|||||
|
2023
Q3 | $872K | Buy |
|
|||||
|
2023
Q2 | $862K | Sell |
|
|||||
|
2023
Q1 | $801K | Buy |
|
|||||
|
2022
Q4 | $919K | Sell |
|
|||||
|
2022
Q3 | $614K | Sell |
|
|||||
|
2022
Q2 | $532K | Buy |
|
|||||
|
2022
Q1 | $366K | Buy |
|
|||||
|
2021
Q4 | $227K | Buy |
|
|||||
|
2021
Q3 | $172K | Buy |
|
|||||
|
2021
Q2 | $197K | Sell |
|
|||||
|
2021
Q1 | $316K | Buy |
|
|||||
|
2020
Q4 | $266K | Sell |
|
|||||
|
2020
Q3 | $434K | Sell |
|
|||||
|
2020
Q2 | $757K | Buy |
|
|||||
|
2020
Q1 | $645K | Buy |
|
|||||
|
2019
Q4 | $481K | Buy |
|
|||||
|
2019
Q3 | $223K | Buy |
|
|||||
|
2019
Q2 | $191K | Buy |
|
|||||
|
2019
Q1 | $56K | Sell |
|
|||||
|
2018
Q4 | $64K | Buy |
|
|||||
|
2018
Q3 | $101K | Sell |
|
|||||
|
2018
Q2 | $96K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $65K | Buy |
|